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Pasteurized Tumoral Autograft as a Novel Procedure for Limb
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Objective—To evaluate use of a pasteurized tumoral autograft prepared from the resected primary
bone neoplasm for limb sparing in a dog with distal radial osteosarcoma (OSA).
Study Design—Clinical case report.
Animals—A 9-year-old male Maremma shepherd dog.
Methods—After right distal radial OSA removal, the tumoral autograft was pasteurized. The excised
bone segment was placed in a sterile watertight box containing sterile saline solution preheated to
65°C in a water bath. The box was kept immersed in the water bath at 65°C for 40 minutes to kill
the tumor cells. The autograft was then fixed in the host with a plate and screws based on standard
AO/ASIF technique for carpal arthrodesis. Three doses of cisplatin (70 mg/m2 intravenously) were
administered, 3 weeks apart; the initial dose was administered the day after surgery.
Results—The autograft was incorporated in a manner comparable to an allograft, and after 708 days,
the metallic implants were removed. A 1-month activity restriction as well as spoon splint to protect
the leg from a full loading were used thereafter. Limb function was fair to good, and the dog remains
disease free after 56 months.
Conclusions—A pasteurized autograft consisting of the resected primary bone neoplasm is a valid
alternative to a cortical bone allograft for limb sparing in dogs with appendicular OSA in terms of
feasibility and pattern of healing.
Clinical Relevance—This procedure can be an alternative method of limb sparing when difficulties
are encountered in establishing and maintaining a canine bone allograft bank.
© Copyright 2002 by The American College of Veterinary Surgeons
OSTEOSARCOMA (OSA) is the most commoncanine bone tumor (85%) and represents 3% to
4% of all canine tumors.1 It is more prevalent in giant
and large dogs, with a median age of 7 years.2 It can
develop anywhere in the skeleton, but the preferential
location is the metaphysis of long bones (75%), in
particular the distal radius.3 Approximately 10% of
dogs have radiologic evidence of lung metastasis at the
time of presentation, but up to 90% of dogs may
already have micrometastasis.3 Therefore, treatment
should be aggressive and addressing both control of
the local disease and the systemic metastasis. Current
treatment protocols are based on a combination of
radical surgery (limb amputation or limb salvage) and
adjuvant chemotherapy.3 We report a limb-sparing
procedure where the excised neoplastic bone was used
after pasteurization as an autograft instead of using a
banked cortical bone allograft.
MATERIALS AND METHODS
A 9-year-old male Maremma shepherd dog (48 kg) was
admitted with a 2-month history of right foreleg lameness.
Other than swelling of the right distal radius/carpus region,
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the dog was in good health, with no lymphadenopathy, and
complete blood count, serum biochemical profile, and
urinalysis results were within the normal range. On radio-
graphs, there was a lytic lesion involving the distal part of
the right radius (Fig 1). Histopathologic examination of a
bone biopsy identified the lesion as a fibroblastic OSA. No
abnormalities were noted on thoracic radiographs. The
tumor was staged as IIB.1
Treatment options were presented to the owner who
elected to have the dog undergo a limb-sparing procedure
using the excised tumor specimen as an autograft after it
had been pasteurized. The dog was premedicated with
acepromazine (0.025 mg/kg intramuscularly [IM]), atropine
(0.02 mg/kg IM), and buprenorphine (0.006 mg/kg IM), and
then anesthesia was induced with. thiopental sodium (8
mg/kg intravenously [IV]) and maintained with isoflurane in
oxygen. Cefazolin (22 mg/kg IV) was administered at
induction of anesthesia and then every 2 hours during
surgery. Care was taken to aseptically prepare the limb
widely to limit bacterial contamination during surgery.
With the dog positioned in right lateral recumbency, an
incision was made along the medial aspect of the antebra-
chium and extended dorsally over the carpal and metacarpal
region. Careful dissection was performed around the distal
radius to isolate the tumor without penetrating it. The
medial branch of the cephalic vein was ligated and
transected. The extensor carpi radialis muscle was
transected proximal to the tumor1; the common digital
extensor tendons were also transected proximal and distal to
the tumor. Care was taken during dissection to preserve
structures of the caudal aspect such as ulnaris lateralis
muscle, flexor muscle digitorum superficialis and profun-
dus, flexor muscle carpi radialis and ulnaris, mediana artery,
ulnaris nerve, and medianus nerve. Radial osteotomy was
performed with an oscillating saw 4 cm proximal to the
proximal extent of the tumor, determined preoperatively
from radiographs. Finally, the distal radius containing the
tumor was removed by disarticulation of the radiocarpal
joint. The radial segment excised was 9.5 cm long; proximal
and distal transverse sections were about 1.5 and 3 cm,
respectively. The ulna was not excised because there was no
radiographic evidence of involvement.
No neoplastic cells were identified in blade-scraping
material collected at the contact points of the 2 pairs of
bones. On cytologic examination of bone marrow collected
from the proximal stump of the neoplastic specimen, no
neoplastic cells were identified, suggesting an adequate
proximal margin. The tumor specimen was cleaned, remov-
ing most of the surrounding soft tissues, and then pasteur-
ized. The excised bone segment was placed in a sterile
watertight box containing sterile saline (0.9% NaCl) solu-
tion preheated to 65°C in a water bath. The box was kept
immersed in the water bath at 65°C for 40 minutes to kill the
tumor cells.4,5 During autograft pasteurization, the carpus
was prepared for arthrodesis by removing all joint cartilage,
then protected by sterile drapes until the autograft was
ready. The articular cartilage was removed from the distal
radius, the periosteum was stripped by scraping, and the
bone marrow was removed by flushing with sterile saline
solution through a pin inserted into the medullary cavity.
Exuberant necrotic tumor was trimmed off the specimen
before final washing in saline solution. The graft was then
repositioned in the leg and stabilized with a 4.5-mm broad
dynamic compression plate and screws using AO/ASIF
technique. Proximally, 5 screws were inserted in the radius,
3 of which also engaged the ulna. Five screws were
positioned distally, 1 in the radial carpal bone and 4 in the
third metacarpus. Three screws were placed into the prox-
imal portion of the autograft, 2 of which also engaged the
ulna (Fig 2). After copious saline lavage, the wound was
closed and a modified Robert Jones bandage was applied
Fig 1. Lateral projection. A lytic lesion is noted at the distal
radius.
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and maintained for 10 days. Cefazolin (20 mg/kg intramus-
cularly, every 12 hours) was administered for 10 days. The
day after surgery, cisplatin chemotherapy (70 mg/m2 IV)
was administered in the middle of a 6-hour hydration period
(17 mL/kg/h saline solution IV). Cisplatin administration
was repeated 2 more times, 21 days apart. Only 3 of the 5
doses of cisplatin normally administered in our treatment
protocol were given because the owner refused further
chemotherapy. Activity was restricted during the first 2
months to short leash walks. The dog was reexamined 10
days after surgery for suture removal, then monthly for the
first 3 months, and every 3 months thereafter for the first
year. Limb and thoracic radiographs and evaluation of limb
function were performed at each examination. After 1 year,
reexamination was scheduled every 6 months. Limb func-
tion was evaluated according to a grading system: excellent
(slight or no lameness), good (mild lameness), fair (evident
lameness), and poor (severe lameness or no use of the
limb).6
RESULTS
Cisplatin therapy was tolerated without any serious
toxicity. Nausea and vomiting were controlled with
metoclopramide (0.2 to 0.4 mg/kg SC). The neutrophil
count did not decrease below 3  103/mL (range, 3 to
11.5  103/mL), and no nephrotoxicity was observed.
Limb function was excellent after 1 month. Al-
though the owner was advised to control the dog’s
activity, this goal was not achieved. This unrestricted
activity stressed the implant system, and at 76 days,
the distal screw became loose and was removed. At
187 days, the proximal 3 of the 4 remaining distal
screws were removed and replaced (Fig 3) because
they were loose or broken. Samples were obtained
from the screws for microbial culture as 2 fistulas had
developed; Staphylococcus spp. was isolated. After the
screws were replaced, the wound was copiously la-
vaged. Amoxicillin-clavulanic acid (15 mg/kg orally,
every 8 hours) was administered for 15 days, based on
antibiotic susceptibility test results. The fistulas re-
solved after 1 week. Local infection periodically
recurred and was treated with antibiotics. The limb
was bandaged at these times to prevent licking.
Incorporation of autograft and progression of the
carpal arthrodesis was monitored radiographically dur-
ing follow-up examinations. Bone union was complete
at 11 months for the intercarpal and carpo-metacarpal
level; however, there was no sign of incorporation of
the autograft, proximally or distally. At 21 months,
there was slight cranial displacement of the autograft
that likely occurred before fusion, and it appeared
deformed but increased in density and was fused both
proximally and distally to the host bone and to the
ulna. Because the plate had loosened and 2 screws had
backed out, the implants were removed (708 days after
surgery, 23.5 months); both host-autograft interfaces
appeared fused (Fig 4). A spoon splint was applied for
1 month, and activity was severely restricted. At day
785 (26 months), limb function was good; however,
there were signs of licking over the dorsal region of
Fig 2. Lateral projection, after surgery. Five screws have
been inserted in the radius, 3 of which engage the ulna (2
completely and 1 partially). Five screws are positioned distally,
1 in the radial carpal bone and 4 in the third metacarpal bone.
The autograft is fixed to the plate only in its proximal part with
3 screws, 2 of which engage the ulna.
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the carpus. At 48 months, we were informed by the
referring veterinarian that trauma had occurred to the
spared limb and that the carpal arthrodesis had likely
broken. Unfortunately, no radiographs were taken
because the owner declined to have the dog evaluated
further; however, we were informed that the dog was
still partially loading the limb and that function was
progressively improving.
At 56 months, on a craniocaudal projection, there
was a large sequestrum corresponding to the old
neoplastic site that was surrounded by a substantial
bone reaction; the distal ends of radius and ulna were
free (Fig 5). Clinically, the dog was in good health;
limb function was fair to good, and there was evi-
dence, by palpation and on limb loading, of pain-free
hyperextension of the manus (Fig 6). These findings
were compatible with atrophic pseudoarthrosis. The
owner declined any further treatment because he
considered the quality of life of his dog’s life to be
good. Current overall survival time and disease-free
interval is 1,683 days (56 months).
DISCUSSION
OSA is the most frequent primary bone tumor in
dogs. Its cause is incompletely understood, but seem-
ingly body weight may play a role in the pathogenesis
of OSA, explaining why most cases are found at the
Fig 3. Lateral projection, 6 months after surgery. The most
distal screw has been removed, and the proximal 3 of the 4
remaining distal screws have been replaced to maintain stabil-
ity. Lytic changes compatible with infection are evident in the
ulna.
Fig 4. Lateral and craniocaudal projections. The plate and
screws have been removed, 708 days (23.5 months) after
surgery.
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distal radius of dogs weighing more than 20 kg.7 Limb
amputation may not always be an option because of
concomitant orthopedic or neurologic problems or
simply because of the owners interest. For these
reasons, several techniques of limb sparing have been
used in dogs.8-11 The most common technique in-
volves the use of fresh-frozen cortical bone allograft
fixed to the host bone with a dynamic compression
plate and screws.1,6,8,12 Arthrodesis of the nearby joint
is usually performed. OSA of the distal radius is the
most common site for use of this technique because
both the soft tissue coverage over the allograft and
function after carpal arthrodesis are good.
Limb sparing in dogs with OSA located at the
proximal humerus, tibia, or distal femur is controver-
sial because arthrodesis of the shoulder or stifle results
in poor or very poor limb function.1,13 For OSA at
these sites and also for the proximal femur, complete
prosthetic replacement has been suggested.1,12 The
distal aspect of the tibia is not an optimal site for limb
sparing because adequate soft tissue coverage over the
allograft is difficult, even if function is acceptable,
when a hock arthrodesis is performed.13 Finally,
osteochondral allografts have been advocated but, at
present, no procedure for preparation and storage is
able to maintain viable chondrocytes.14
Bone transport osteogenesis involving the use of the
Ilizarov apparatus has also been used as a limb-sparing
procedure for distal radial OSA. Initial reports indicate
that this is a promising technique.15
Each technique has advantages and disadvantages.
In general, all limb-sparing techniques are delicate
surgical procedures that require expertise, knowledge
of the potential complications, a dedicated owner, a
treatable animal, and cooperation between surgeon,
chemotherapist, and owner. The use of cortical bone
allografts requires periodic maintenance of a bank of
sterile frozen bone that must be aseptically harvested
from dogs free of contagious and neoplastic diseases;
such dogs may not always be available. Bone banking
may also not be allowed in certain countries. A
minimum of 15 days of freezing has been suggested to
decrease the immunogenicity of a bone allograft that
has been cleaned of all soft tissues, periosteum, and
bone marrow.16,17 If stored at 20°C, the allograft
should be used within 1 year because biomechanical
properties begin to deteriorate after that time.18 Cor-
tical bone allografts prepared by freezing, freeze
drying, or decalcification do not provide living cells.
The healing process depends on the allograft’s ability
to induce osteoinduction in the recipient14; the allo-
graft also provides a mechanical support to the new
bone growth (osteoconduction).19 Firstly, the bone
graft undergoes centripetally, intense osteoclastic ac-
tivity with tunnel formation, and enlargement of How-
ships’ lacunae; then vascular buds and ossification
fronts invade the resorption sites. Finally, new bone is
formed so that it partially substitutes and partially
overlaps the necrotic bone of the graft (creeping
substitution).20,21
Other techniques of bone graft preparation also have
Fig 5. Lateral (A) and craniocaudal (B) projections at 56
months. (A) The distal end of radius is free. (B) A sequestrum
corresponding to the old neoplastic lesion surrounded by a
thick bone reaction is evident; the distal end of ulna appears
free.
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disadvantages. Osteoinductivity seems to decrease or
be eliminated when boiling, autoclaving, or high-dose
radiation are used.14,18 It has been suggested that
chemicals used for chemical sterilization may act as
carcinogens.14 In general, all preparation techniques,
including freezing, result in decreased graft strength.22
Successful use of pasteurized autografts from the
bone tumor have been reported in humans.4,5 Because
of these reports and our difficulty identifying dogs as
bone donors for our own frozen allograft bank, we
modified our limb-sparing protocol to include use of
the pasteurization procedure. The healing we observed
in this dog was comparable to that observed in our
dogs with frozen allografts.6 We have had good
experience with this technique in other dogs23 but are
only reporting on this dog in detail because it has the
longest follow-up, is still alive, has not had local
recurrence or lung metastasis, and had plate removal.
Based on our clinical experience and low recurrence
rate, we can affirm that pasteurization is able to kill
tumor cells as reported in humans.4,5 Healing as
observed in this dog may also imply a preserved,
although decreased, osteoinductivity, but this needs
further investigation.
Local infection is the most common non–tumor-
related complication after limb sparing. Rarely does it
result in complete failure of the procedure. Local
infection results from extensive surgical resection and
vascular damage, duration of the procedure, implanta-
tion of nonvascularized bone and metallic devices,
limited soft tissue coverage, chemotherapy, presence
of undetected foci of infection somewhere in the body
before surgery, and licking.24 Measures to prevent
infection include the adoption of strict aseptic surgical
technique, perioperative and intraoperative adminis-
tration of intravenous antibiotics, and prevention from
licking and any other postsurgical trauma. Variable
degrees of infection are observed. Recurrent wound
drainage is the most frequent form and is usually
controlled with systemic antibiotics and basic wound
management, as occurred in this dog. Pasteurization
did not limit this complication, although it did not
seriously impede bone healing.
Implant failure is the second most frequent non–
tumor-related complication associated with limb spar-
ing. Causes may be an uncontrollable infection or
implant instability. The latter may be caused by
resection of more than 50% of the length of the bone
and substitution with a long bone graft causing tech-
nical problems such as the positioning of an insuffi-
cient number of proximal or distal screws, depending
on tumor location.24 Another cause for implant failure
may be an excess of activity of the animal, as occurred
in our dog. Loosening of the implants necessitated
Fig 6. Frontal (A) and lateral (B) view at 56 months. Note the hyperextension of the manus of the right forelimb.
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their removal, which also resulted in improvement of
both the chronic bone infection and the skin lesions
caused by licking.
The limited number of screws that were placed in
the autograft because of the extensive bone destruction
caused by the tumor may represent a major drawback
for this technique because of resultant implant insta-
bility. The outcome in this dog and in others23 does
not suggest that it is a limiting factor when the
orthopedic devices are in place, but problems may
arise when they are removed. However, it is the
authors’ conviction that similar problems may also
arise when other limb-sparing procedures are used.
Consideration might be given to the use of polymeth-
ylmethacrylate and autologous cancellous bone grafts
to increase stability. It is possible that a cancellous
bone graft may have improved the strength of the
radiocarpal arthrodesis.
Local recurrence is the major tumor-related local
complication of limb sparing. Complete excision of
OSA is not always achieved because of undetected
extension into the surrounding soft tissue and incom-
plete removal of neoplastic bone by ostectomy. Local
recurrence is certainly a distressing event, but it is not
necessarily a life-threatening problem because limb
amputation can be performed. A reduction of local
recurrence in limb sparing (from 27% to 17%) has
been achieved through the use of a slow-release
cisplatin product in the surgical wound.25 Evaluation
of recent radiographs to determine the extent of radial
ostectomy,26 combined with intraoperative cytologic
examination of surrounding tissues and bone marrow
at the resection site, is useful to establish that a clean
resection occurred. In this dog, the ulna was not
removed because it appeared radiographically not to
be involved and neoplastic cells were not identified on
intraoperative cytologic examination. Sparing the ulna
provided increased stability to the implant system.
Finally, lack of recurrence in this dog may indicate
that the pasteurization process killed the tumor.
Adjuvant chemotherapy is indicated because sur-
gery alone should only be considered palliative. Sur-
vival is not affected by the surgical procedure (ampu-
tation v limb sparing) if adjuvant chemotherapy is
used.1 Commonly administered chemotherapeutic
drugs are cisplatin,1,27 doxorubicin,28 cisplatin alter-
nated with doxorubicin,29,30 and carboplatin.31 Be-
cause of the owner’s refusal to pursue the standard
protocol (5 doses), this dog received only 3 doses of
cisplatin; however, there was no evidence of lung
metastasis.
We conclude that the use of a pasteurized bone graft
derived from the resected primary bone neoplasm is a
valid alternative to the use of a frozen cortical bone
allograft for limb sparing in dogs with distal radial
OSA. This procedure is indicated when difficulty is
encountered establishing and maintaining a canine
bone allograft bank.
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